Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Harvard Bioscience (HBIO) Gross Profit (2016 - 2025)

Historic Gross Profit for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $12.0 million.

  • Harvard Bioscience's Gross Profit fell 582.84% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 1284.34%. This contributed to the annual value of $54.8 million for FY2024, which is 1711.04% down from last year.
  • Harvard Bioscience's Gross Profit amounted to $12.0 million in Q3 2025, which was down 582.84% from $11.5 million recorded in Q2 2025.
  • Over the past 5 years, Harvard Bioscience's Gross Profit peaked at $19.6 million during Q4 2021, and registered a low of $11.5 million during Q2 2025.
  • Moreover, its 5-year median value for Gross Profit was $15.4 million (2021), whereas its average is $15.0 million.
  • Per our database at Business Quant, Harvard Bioscience's Gross Profit crashed by 2536.18% in 2022 and then skyrocketed by 2099.08% in 2023.
  • Harvard Bioscience's Gross Profit (Quarter) stood at $19.6 million in 2021, then decreased by 19.05% to $15.8 million in 2022, then grew by 3.11% to $16.3 million in 2023, then dropped by 14.17% to $14.0 million in 2024, then decreased by 14.2% to $12.0 million in 2025.
  • Its last three reported values are $12.0 million in Q3 2025, $11.5 million for Q2 2025, and $12.2 million during Q1 2025.